Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-22-019949
Filing Date
2022-08-01
Accepted
2022-08-01 16:13:22
Documents
1
Period of Report
2022-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165938478001230.html 4  
1 FORM 4 wf-form4_165938478001230.xml 4 6179
  Complete submission text file 0001628280-22-019949.txt   7527
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Issuer) CIK: 0001600620 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address #1203-4464 MARKHAM STREET VICTORIA A1 V8Z7X8
Business Address
Habig Scott Michael (Reporting) CIK: 0001938159 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36421 | Film No.: 221124883